Skip to content
POM-VPS Prescription Required

Bimectin 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs

Active ingredient: Ivermectin

Form

Injection

Species

Cattle Pigs Sheep

Manufacturer

Bimeda Animal Health Limited

VMD MA No.

50146/4002

What it's used for

Haemonchus placei Trichostrongylus axei T. colubriformis Cooperia spp. Bunostomum phlebotomum Oesophagostomum radiatum Strongyloides papillosus (adult) Nem...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Ivermectin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Bimectin 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Haemonchus placei
Trichostrongylus axei
T. colubriformis
Cooperia spp.
Bunostomum phlebotomum
Oesophagostomum radiatum
Strongyloides papillosus (adult)
Nematodirus helvetianus (adult)
N. spathiger (adult)
Trichuris spp (adult)
Lungworms (adult and fourth-stage larvae):
AN: 01909/2024 & 01910/2024
Dictyocaulus viviparous
Eye worms (adult):
Thelazia spp.
Warbles:
Hypoderma bovis
H. lineatum
Mange mites:
Psoroptes bovis
Sarcoptes scabiei var. bovis
Sucking lice:
Linognathus vituli
Haematopinus eurysternus
Solenopotes capillatus
May also be used as an aid in the control of the mange mite Chorioptes bovis and biting
lice , but complete elimination may not occur.
Persistent Activity
Treatment at the recommended dose rate can control re-infection with Haemonchus placei
and Cooperia spp. acquired up to 14 days after treatment, Ostertagia ostertagi and
Oesophagostomum radiatum acquired up to 21 days after treatment and Dictyocaulus
viviparus up to 28 days after treatment.
To obtain optimal benefit from the persistent activity of the veterinary medicinal product for
grazing animals, it is recommended that calves which are set-stocked in the first grazing
season should be treated 3, 8 and 13 weeks after the day of turn-out. This can protect the
animals from parasitic gastroenteritis and lungworm disease throughout the grazing
season, provided they are set-stocked, all the calves included in the programme and that
no untreated cattle are added to the pasture. Treated animals should always be monitored
according to good husbandry practices.
Sheep:
Gastrointestinal roundworms (adult and fourth-stage larvae):
Ostertagia circumcincta including inhibited larvae
O. trifurcate
Haemonchus contortus including inhibited larvae
Trichostrongylus axei (adult)
T. colubriformis T. vitrinus
Cooperia curticei
Oesophagostomum columbianum
O. venulosum (adult)
Nematodirus filicollis
Chabertia ovina
Trichuris ovis (adult)
AN: 01909/2024 & 01910/2024
Lungworms:
Dictyocaulus filaria (adult and fourth-stage larvae)
Protostrongylus rufescens (adult)
Nasal Bots (all larval stages):
Oestrus ovis
Pigs:
Gastrointestinal roundworms (adult and fourth-stage larvae):
Ascaris suum
Hyostrongylus rubidus
Oesophagostomum spp.
Strongyloides ransomi
Lungworms:
Metastrongylus spp. (adult)
Lice:
Haematopinus suis
Mange mites:
Sarcoptes scabiei var. suis
The veterinary medicinal product should be given only by subcutaneous injection at the
recommended dosage level of 200 mcg ivermectin per kg bodyweight under the loose skin
in front of, or behind, the shoulder in cattle and over the neck in sheep. At the
recommended dosage level of 300 mcg ivermectin per kg of bodyweight, the veterinary
medicinal product should be given only subcutaneously in the neck of pigs.
Each ml contains 10 mg of ivermectin sufficient to treat 50 kg of bodyweight of cattle and
sheep and 33 kg of bodyweight of pigs. The injection may be given with any standard
automatic or single-dose or hypodermic syringe. Use of 17 gauge x ½ inch needle is
suggested. Replace with a fresh sterile needle after every 10 to 12 animals.
Injection of wet or dirty animals is not recommended. If using a single-dose or hypodermic
syringe, use a separate sterile needle to withdraw the veterinary medicinal product from
the container. Massage the injection site after administration of the veterinary medicinal
product.
In young pigs, especially those below 16 kg for which less than 0.5 ml of the veterinary
medicinal product is indicated, dosing accuracy is important. The use of a syringe that can
accurately deliver as little as 0.1 ml is recommended.
In young lambs weighing less than 20.0 kg give 0.1 ml per 5 kg. In these lambs the use of
a syringe with can deliver as little as 0.1 ml is recommended.
To ensure a correct dosage, body weight should be determined as accurately as possible;
accuracy of the dosing device should be checked.
The use of suitably calibrated measuring equipment is recommended.
If animals are to be treated collectively rather than individually, they should be grouped
according to their bodyweight and dosed accordingly, in order to avoid under- or over-
dosing.
AN: 01909/2024 & 01910/2024
Do not use in cases of hypersensitivity to the active ingredient or to any of the excipients.
Do not use by intramuscular or intravenous administration.
Cattle, Sheep and Pigs:
Undetermined frequency
(cannot be estimated from the
available data):
Injection site pain
1,2

Injection site swelling
1
Mild and transient following subcutaneous administration.
In sheep: sometimes intense.
In cattle only.
All these reactions disappeared without treatment.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
Care should be taken to avoid the following practices because they increase the risk of
development of resistance and could ultimately result in ineffective therapy:
-
period of time.
-
of the veterinary medicinal product, or lack of calibration of the dosing device.
Suspected clinical cases of resistance to anthelmintics should be further investigated using
appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s)
strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to
another pharmacological class and having a different mode of action should be used.
Resistance to ivermectin has been reported in Teladorsagia circumcincta in sheep and
Ostertagia ostertagi in cattle. Therefore, the use of this veterinary medicinal product should
be based on local (regional, farm) epidemiological information about susceptibility of these
helminth species and recommendations on how to limit further selection for resistance to
anthelmintics.
AN: 01909/2024 & 01910/2024

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Take care to avoid self-administration: the veterinary medicinal product may cause local
irritation and/or pain at the site of injection.
Direct contact of the veterinary medicinal product with the skin should be kept to a
minimum.
Do not smoke or eat while handling the veterinary medicinal product.
Wash hands after use.
Special precautions for the protection of the environment:
See section 5.5.
Other precautions:
When using the 250 ml and 500 ml pack sizes, use only automatic syringe equipment. For
the 50 ml pack size, use of a multiple dose syringe is recommended. To refill the syringe,
use of a draw off needle is recommended to avoid excessive broaching of the stopper.
The veterinary medicinal product has been formulated specifically for use in cattle, sheep
and pigs. It should not be used in other species as severe adverse reactions, including
fatalities in dogs, may occur.
The veterinary medicinal product can be used concurrently without adverse effects with
foot and mouth disease vaccine or clostridial vaccine, given at separate injection sites.
This veterinary medicinal product does not require any special storage conditions.
Cattle:
Meat and offal: 49 days.
Milk: Do not use in lactating cows producing milk for human consumption. Do not use in
non-lactating dairy cows including pregnant dairy heifers within 60 days of calving.
Sheep:
Meat and offal: 42 days.
Milk: Do not use in lactating sheep producing milk for human consumption. Do not use in
sheep within 60 days of lambing where milk is to be used for human consumption.
Pigs:
Meat and offal: 28 days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.